Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.160
-0.030 (-2.52%)
At close: Oct 5, 2026, 4:00 PM EDT
1.200
+0.040 (3.45%)
After-hours: Oct 5, 2026, 7:59 PM EDT
Spero Therapeutics Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Spero Therapeutics stock has a consensus rating of "Buy" and an average price target of $5.00. The average 1-year stock price forecast is 331.03% higher than the current stock price, while the lowest is $4.00 (+244.83%) and the highest is $6.00 (+417.24%).
Price Target: $5.00 (+331.03%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Spero Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Mar '26 | Jun '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 1 | 1 | 2 |
Financial Forecast
Revenue This Year
258.00K
from 66.80M
Decreased by -99.61%
Revenue Next Year
n/a
from 258.00K
Decreased by -100.00%
EPS This Year
-1.98
EPS Next Year
-1.78
from -1.98
EPS and Forward PE are based on non-GAAP adjusted numbers.